ESC 365 - Associate Professor Elad Maor

Speaker illustration

Associate Professor Elad Maor

Sheba Medical Center, Tel Aviv (Israel)

Member of:

Serum uric acid levels significantly improve the accuracy of cardiovascular risk score models

Event: ESC Congress 2022

Topic: Scores

Session: Cardiovascular risk assessment - Scores 2

The real-world safety profile of SGLT2 inhibitors among adults 75 years or older: a retrospective, pharmacovigilance study

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: SGLT2 inhibitors: pearls from recent trials and surveys

Decreasing albumin within normal range is associated with increased likelihood of ischemic heart disease

Event: ESC Congress 2022

Topic: Biomarkers

Session: Cardiovascular risk assessment - Biomarkers 1

Right ventricular function and systolic pressure effect on survival of patients with tricuspid regurgitation

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Valvular Heart Disease ePosters

Vocal biomarker predicts long term survival among heart failure patients

Event: ESC Congress 2018

Topic: Biomarkers

Session: The potential of new and unusual biomarkers in heart failure

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources